Two Sigma Investments LP cut its position in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 54.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 12,608 shares of the company's stock after selling 14,782 shares during the quarter. Two Sigma Investments LP owned 0.07% of Addus HomeCare worth $1,580,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors and hedge funds have also made changes to their positions in the company. Natixis boosted its stake in Addus HomeCare by 111.9% during the 4th quarter. Natixis now owns 250 shares of the company's stock valued at $31,000 after acquiring an additional 132 shares during the last quarter. Smartleaf Asset Management LLC boosted its stake in Addus HomeCare by 324.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 280 shares of the company's stock valued at $35,000 after acquiring an additional 214 shares during the last quarter. Parkside Financial Bank & Trust boosted its stake in Addus HomeCare by 38.6% during the 4th quarter. Parkside Financial Bank & Trust now owns 531 shares of the company's stock valued at $67,000 after acquiring an additional 148 shares during the last quarter. Meeder Asset Management Inc. bought a new position in Addus HomeCare during the 4th quarter valued at $77,000. Finally, Harvest Fund Management Co. Ltd bought a new position in Addus HomeCare during the 4th quarter valued at $86,000. 95.35% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
A number of research analysts have commented on ADUS shares. Macquarie increased their price objective on shares of Addus HomeCare from $129.00 to $133.00 and gave the company an "outperform" rating in a research note on Thursday, May 8th. JMP Securities reissued a "market outperform" rating and set a $150.00 target price on shares of Addus HomeCare in a report on Tuesday, April 22nd. Stephens reissued an "overweight" rating and set a $142.00 target price on shares of Addus HomeCare in a report on Wednesday, March 12th. Finally, Wall Street Zen cut shares of Addus HomeCare from a "buy" rating to a "hold" rating in a report on Wednesday, February 26th. One research analyst has rated the stock with a hold rating, six have issued a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Buy" and an average price target of $142.57.
Read Our Latest Analysis on ADUS
Addus HomeCare Price Performance
Shares of ADUS stock traded up $0.15 during trading hours on Thursday, reaching $112.16. The stock had a trading volume of 123,193 shares, compared to its average volume of 169,257. Addus HomeCare Co. has a twelve month low of $88.96 and a twelve month high of $136.72. The firm has a 50-day simple moving average of $105.35 and a 200-day simple moving average of $112.60. The firm has a market capitalization of $2.06 billion, a PE ratio of 25.67, a price-to-earnings-growth ratio of 1.41 and a beta of 0.85.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its quarterly earnings data on Monday, May 5th. The company reported $1.42 earnings per share for the quarter, topping analysts' consensus estimates of $1.33 by $0.09. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The business had revenue of $337.71 million for the quarter, compared to analysts' expectations of $341.66 million. During the same quarter last year, the company earned $1.21 EPS. The company's revenue for the quarter was up 20.3% compared to the same quarter last year. On average, equities analysts anticipate that Addus HomeCare Co. will post 4.59 earnings per share for the current year.
Insider Buying and Selling
In related news, EVP Michael D. Wattenbarger sold 2,045 shares of the stock in a transaction dated Tuesday, May 27th. The shares were sold at an average price of $115.00, for a total value of $235,175.00. Following the completion of the transaction, the executive vice president now owns 7,796 shares in the company, valued at $896,540. This represents a 20.78% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Corporate insiders own 4.60% of the company's stock.
Addus HomeCare Profile
(
Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
See Also

Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.